Kawasaki disease: a comprehensive review
DOI:
https://doi.org/10.12775/JEHS.2022.12.08.032Keywords
Kawasaki disease, IVIG, aspirin, coronary aneurysm, vasculitisAbstract
Introduction and purpose: Kawasaki disease is an acute, self-limited vasculitis of medium arteries, and it affects children under 5 years old. It can lead to coronary artery aneurysms.
Brief description of the state of knowledge: Pathogenesis of Kawasaki disease is unclear. The diagnosis is based on the clinical findings. The characteristic symptoms are polymorphous skin rashes, conjunctivitis, erythema, dryness, cracking and bleeding of the lips, erythema and swelling of palms and soles and cervical lymphadenopathy. Kawasaki disease is defined as a fever for 5 days accompanied by 4 or more of the diagnostic symptoms described above. The classic diagnosis is based on the exclusion of other diseases too. The diagnosis of incomplete Kawasaki disease is suggested if less than 4 main clinical features are found. It is the most common cause of acquired heart disease in children. Kawasaki disease can lead to coronary artery aneurysm, myocarditis and pericarditis so it is very important to treat this illness correctly. Basic treatment is a single infusion of intravenous immunoglobulin and high-dose aspirin. Recurrent Kawasaki disease (persistent fever after first line treatment with IVIG and aspirin) requires the same treatment as used for the first episode. Corticosteroids and immune-modulating therapies can be used as second and third line options. Quick recognition and early treatment result in a reduction of coronary artery abnormalities.
Conclusion: This article reviews basic informations, history, epidemiology, pathophysiology, clinical presentation, diagnostic criteria, complications and treatment of Kawasaki disease.
References
Hedrich CM, Schnabel A, Hospach T. Kawasaki Disease. Front Pediatr. 2018 Jul 10;6:198. doi: 10.3389/fped.2018.00198. PMID: 30042935; PMCID: PMC6048561.
Brogan, P. A. (2002). Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Archives of Disease in Childhood, 86(4), 286–290. doi:10.1136/adc.86.4.286
Ramphul K, Mejias SG. Kawasaki disease: a comprehensive review. Arch Med Sci Atheroscler Dis. 2018 Mar 21;3:e41-e45. doi: 10.5114/amsad.2018.74522. PMID: 30775588; PMCID: PMC6374576.
Rife, E., Gedalia, A. Kawasaki Disease: an Update. CurrRheumatol Rep 22, 75 (2020). https://doi.org/10.1007/s11926-020-00941-4
Jamieson N, Singh-Grewal D. Kawasaki Disease: A Clinician's Update. Int J Pediatr. 2013;2013:645391. doi: 10.1155/2013/645391. Epub 2013 Oct 27. PMID: 24282419; PMCID: PMC3826559.
Galuppo, Jana PA-C; Kowker, Alexandra PA-C; Rolfs, Jenna PA-C; Nicholas, Joyce PhD; Schmidt, EricPhD Kawasaki disease, JAAPA: July 2020 - Volume 33 - Issue 7 - p 18-22 doi: 10.1097/01.JAA.0000668792.41976.f2
Shiari, Reza. (2013). Kawasaki Disease; A Review Article. Archives of Pediatric Infectious Diseases. 4. 154-9. 10.5812/pedinfect.11628.
Smorczewska-Kiljan A, Marszał M, Friedman-Gruszczyńska J, Wieteska-Klimczak A, Książyk J, Jaworski M, Buda P. Clinical characteristics of Kawasaki disease in Polish children: A retrospective study. Kardiol Pol. 2022;80(6):657-663. doi: 10.33963/KP.a2022.0090. Epub 2022 Apr 5. PMID: 35380006.
McCrindle, B. W., Rowley, A. H., Newburger, J. W., Burns, J. C., Bolger, A. F., Gewitz, M., Pahl, E. (2017). Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation, 135(17), e927–e999. doi:10.1161/cir.0000000000000484
Newburger J, Takahashi M, Burns J, et al. Kawasaki Disease. J Am Coll Cardiol. 2016 Apr, 67 (14) 1738–1749.https://doi.org/10.1016/j.jacc.2015.12.073
Gowin E, Małecka I, Stryczyńska-Kazubska J, Michalak M, Wysocki J, Górzna-Kamińska H. Cardiac complications in children with Kawasaki disease in our own experience. Kardiol Pol. 2016;74(1):75-82. doi: 10.5603/KP.a2015.0136. Epub 2015 Jul 23. PMID: 26202530.
Gerding R. Kawasaki disease: a review. J Pediatr Health Care. 2011 Nov-Dec;25(6):379-87. doi: 10.1016/j.pedhc.2011.07.007. PMID: 22018429.
Harnden A, Takahashi M, Burgner D. Kawasaki disease. BMJ. 2009 May 5;338:b1514. doi: 10.1136/bmj.b1514. PMID: 19416993.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004 Oct 26;110(17):2747-71. doi: 10.1161/01.CIR.0000145143.19711.78. PMID: 15505111
Saguil A, Fargo M, Grogan S. Diagnosis and management of kawasaki disease. Am Fam Physician. 2015 Mar 15;91(6):365-71. PMID: 25822554.
Marchesi, A., Rigante, D., Cimaz, R. et al. Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease. Ital J Pediatr 47, 16 (2021). https://doi.org/10.1186/s13052-021-00962-4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Aleksandra Osiejewska, Dominika Wojtachnio, Jakub Bartoszewicz, Anna Grądzik, Izabela Nowakowska, Małgorzata Kudan, Anna Gorajek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 1163
Number of citations: 0